Skip to main content
Premium Trial:

Request an Annual Quote

NIH Chemical Genomics Program Extends Simulations Plus License

NEW YORK (GenomeWeb News) – Pharmaceutical software company Simulations Plus said on Thursday that the National Institutes of Health has renewed a license agreement for the company’s cheminformatics screening platform.
 
The Lancaster, Calif.-based company said that the NIH has renewed five licenses for the company’s ClassPharmer software, which it will use in its Chemical Genomics program.
 
The licenses were originally struck in August of 2007, and have now been renewed for another year.
 
The ClassPharmer software includes data analysis features for intuitive class generation, querying and similarity screening, data visualization and filtering, and other functions.
 
Financial terms of the agreement were not released.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.